BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36129469)

  • 1. CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer.
    Shi W; Fijardo M; Bruce JP; Su J; Xu W; Bell R; Bissey PA; Hui ABY; Waldron J; Pugh TJ; Yip KW; Liu FF
    Clin Cancer Res; 2022 Dec; 28(23):5202-5210. PubMed ID: 36129469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
    Zhang R; Liao X; Zhang B; Huang X; Qin G; Kong X; Xie Y; Mo Y; Dai J; Gan C; Luo Z; Lu J; Jiang W
    Pathol Res Pract; 2024 Jan; 253():154936. PubMed ID: 38006840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
    Berele BA; Cai Y; Yang G
    Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer.
    Zhou F; Shayan G; Sun S; Huang X; Chen X; Wang K; Qu Y; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Shi X; Liu Y; Liang B; Li YX; Wang J; Yi J
    Front Immunol; 2022; 13():1015283. PubMed ID: 36439177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Liu W; Chen G; Zhang C; Liao X; Xie J; Liang T; Liao W; Song L; Zhang X
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):25-35. PubMed ID: 34027599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
    Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology.
    Wang YQ; Chen L; Mao YP; Li YQ; Jiang W; Xu SY; Zhang Y; Chen YP; Li XM; He QM; He SW; Yang XJ; Lei Y; Zhao Y; Yun JP; Liu N; Li Y; Ma J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Mohammed SF; Khoja HA; Al-Dehaim M; Ghebeh H
    Medicine (Baltimore); 2021 Nov; 100(46):e27956. PubMed ID: 34797353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
    BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
    Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
    Li J; Wang J; Chen R; Bai Y; Lu X
    Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.
    Zhang YL; Li J; Mo HY; Qiu F; Zheng LM; Qian CN; Zeng YX
    Mol Cancer; 2010 Jan; 9():4. PubMed ID: 20064222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma.
    Zhao J; Guo C; Xiong F; Yu J; Ge J; Wang H; Liao Q; Zhou Y; Gong Q; Xiang B; Zhou M; Li X; Li G; Xiong W; Fang J; Zeng Z
    Cancer Lett; 2020 May; 477():131-143. PubMed ID: 32061950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Lu J; Chen XM; Huang HR; Zhao FP; Wang F; Liu X; Li XP
    Head Neck; 2018 Jun; 40(6):1245-1253. PubMed ID: 29493822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of tumor PD-L1 expression combined with CD8
    Wang Q; Lou W; Di W; Wu X
    Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.